Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens.

Journal: eLife

Published: 2020-08-04

DOI: 10.7554/elife.57659

Affiliations: 12

Authors: 25

Go to article
Institutions Share
UW Medicine, United States of America (USA) 0.23
University of Washington (UW), United States of America (USA) 0.17
NIH NIAID Vaccine Research Center (VRC), United States of America (USA) 0.16
Cornell University, United States of America (USA) 0.14
Lawrence Berkeley National Laboratory (LBNL), United States of America (USA) 0.08
Scripps Research, United States of America (USA) 0.06
Collaboration for AIDS Vaccine Discovery (CAVD), United States of America (USA) 0.06
Amsterdam UMC, Netherlands 0.06
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA) 0.04

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER